Clinical Trials on Stent-Graft Endoleak in Norway
Total 19 results
-
Tor Erik SandUnknownUreteric Stent After Stone SurgeryNorway
-
Oslo University HospitalCompletedGraft-Versus-Host DiseaseNorway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; SINTEF Health ResearchCompleted
-
Norwegian University of Science and TechnologySt. Olavs Hospital; SINTEF Health ResearchTerminatedAbdominal Aortic Aneurysm | EndoleakNorway
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and TechnologyCompletedCutaneous T-Cell Lymphoma, Unspecified | Chronic Graft Versus Host Disease in SkinNorway
-
Tampere UniversityBoston Scientific CorporationCompletedRestenosis | Stent ThrombosisNorway, Sweden, Denmark, Finland, Latvia
-
Oslo University HospitalCompletedQuality of Life | Stem Cell Transplant Complications | GVH - Graft Versus Host ReactionNorway
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedKidney Transplantation | Graft vs Host DiseaseNorway, Sweden
-
Nantes University HospitalNot yet recruiting
-
Oslo University HospitalActive, not recruitingAortoiliac Occlusive Disease | Aortobifemoral Bypass | TASC Type D Lesions | Laparoscopic Versus Open Bifurcation GraftNorway
-
Millennium Pharmaceuticals, Inc.TerminatedAllogeneic Hematopoietic Stem Cell TransplantationUnited States, Belgium, Sweden, France, Norway
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
Millennium Pharmaceuticals, Inc.CompletedHematopoietic Stem CellsUnited States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
-
Novartis PharmaceuticalsCompletedGraft RejectionUnited Kingdom, Canada, Taiwan, United States, France, Belgium, Spain, Australia, Germany, New Zealand, Argentina, Italy, Austria, Norway, Puerto Rico
-
Abbott Medical DevicesCompletedMyocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery RestenosisItaly, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
-
Abbott Medical DevicesTerminatedAtrial Fibrillation | Coronary Arteriosclerosis | Coronary Artery Bypass Graft SurgeryCanada, United Kingdom, Netherlands, Norway, Finland, Germany
-
Abbott Medical DevicesCompletedMyocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery RestenosisFrance, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
-
Janssen Research & Development, LLCPharmacyclics LLC.Enrolling by invitationFollicular Lymphoma | Chronic Graft Versus Host Disease | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic LymphomaUnited States, Spain, United Kingdom, Israel, Canada, Belgium, Poland, China, Japan, France, Korea, Republic of, Australia, Russian Federation, Turkey, Sweden, Italy, Mexico, Czechia, Ukraine, Brazil, Hungary, Portugal, Argentina, Col... and more